Ask FDA to Finalize Guidance for ALS and Right to Try

We have made great strides in treating many life-threatening diseases, but treatment for ALS (Lou Gehrig’s disease) has lagged behind.  Unfortunately, this rare but devastating disease is fast-acting once diagnosed and affords little opportunity for study. 
Families are often left scrambling to adapt and have little time to advocate for federal policy changes.  Yet I, and many of my colleagues, have had the opportunity to get to know victims and their families, and it’s up to us to advocate on their behalf. 
Fortunately, there are opportunities to make a difference.

Read More

Address the TPS Crisis

I invite you to cosponsor H.R. 6696, the TPS Extension Act.  This legislation, if enacted, would extend the government program known as Temporary Protection Status (TPS) for all current beneficiaries through September 15, 2021. Currently, the ten countries
that participate in TPS all have expiring dates ranging from November 2018 (Sudan) into 2020 (Honduras, Yemen).

Read More